ATA425280A - Verfahren zur herstellung von neuen 2-phenyl-imidazo(2.1-b)-benzothiazolderivaten - Google Patents

Verfahren zur herstellung von neuen 2-phenyl-imidazo(2.1-b)-benzothiazolderivaten

Info

Publication number
ATA425280A
ATA425280A AT0425280A AT425280A ATA425280A AT A425280 A ATA425280 A AT A425280A AT 0425280 A AT0425280 A AT 0425280A AT 425280 A AT425280 A AT 425280A AT A425280 A ATA425280 A AT A425280A
Authority
AT
Austria
Prior art keywords
imidazo
phenyl
producing new
benzothiazole derivatives
benzothiazole
Prior art date
Application number
AT0425280A
Other languages
English (en)
Inventor
Kiyoshi Murase
Toshiyasu Mase
Kenichi Tomioka
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP10643879A external-priority patent/JPS5630990A/ja
Priority claimed from JP14507779A external-priority patent/JPS5668685A/ja
Priority claimed from JP14844179A external-priority patent/JPS5671096A/ja
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Publication of ATA425280A publication Critical patent/ATA425280A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT0425280A 1979-08-21 1980-08-20 Verfahren zur herstellung von neuen 2-phenyl-imidazo(2.1-b)-benzothiazolderivaten ATA425280A (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP10643879A JPS5630990A (en) 1979-08-21 1979-08-21 2-phenylimidazo 2,1-b benzothiazole derivative and its preparation
JP14507779A JPS5668685A (en) 1979-11-09 1979-11-09 2-phenylimidazo 2,1-b benzothiazole derivative and its preparation
JP14844179A JPS5671096A (en) 1979-11-16 1979-11-16 2-phenylimidazo 2,1-b- benzothiazole derivative

Publications (1)

Publication Number Publication Date
ATA425280A true ATA425280A (de) 1986-01-15

Family

ID=27310731

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0425280A ATA425280A (de) 1979-08-21 1980-08-20 Verfahren zur herstellung von neuen 2-phenyl-imidazo(2.1-b)-benzothiazolderivaten

Country Status (8)

Country Link
US (1) US4497817A (de)
AT (1) ATA425280A (de)
CA (1) CA1158246A (de)
DE (1) DE3030982A1 (de)
ES (1) ES8106535A1 (de)
FR (1) FR2463774A1 (de)
GB (1) GB2056982B (de)
IT (1) IT1166483B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464384A (en) * 1981-12-23 1984-08-07 Yamanouchi Pharmaceutical Co., Ltd. 2-Phenylimidazo[2,1-b]benzothiazole compounds, salts thereof, process of producing them, and pharmaceutical compositions containing them
JP2726999B2 (ja) * 1988-06-22 1998-03-11 日研化学株式会社 イミダゾ［２，１−ｂ］ベンゾチアゾール誘導体及び該化合物を有効成分とする抗潰瘍剤
IT1243362B (it) * 1990-07-25 1994-06-10 Pietro Monforte Sintesi di attivita' anti-hiv di 1h, 3h-tiazolo 3,4-a benzimidazoli 1-sostituiti
JP3178843B2 (ja) * 1995-03-13 2001-06-25 日研化学株式会社 イミダゾチアゾール化合物
AU3783497A (en) * 1996-08-09 1998-03-06 Yamanouchi Pharmaceutical Co., Ltd. Metabotropic glutamate receptor agonists
US6127387A (en) * 1996-12-10 2000-10-03 Thomas Jefferson University Use of CD4-binding small molecules to inhibit immune responses
EP1143943B1 (de) * 1999-01-29 2007-12-12 The Board Of Trustees Of The University Of Illinois VERWENDUNG VON p53 INHIBITOREN ZUR BEHANDLUNG VON NEBENERSCHEINUNGEN BEI DER KREBSTHERAPIE
DE19948436B4 (de) * 1999-10-08 2006-11-16 Grünenthal GmbH Bicyclische Imidazo-5-aminderivate
DE19948434A1 (de) * 1999-10-08 2001-06-07 Gruenenthal Gmbh Substanzbibliothek enthaltend bicyclische Imidazo-5-amine und/oder bicyclische Imidazo-3-amine
US6867299B2 (en) 2000-02-24 2005-03-15 Hoffmann-La Roche Inc. Oxamide IMPDH inhibitors
US7601846B2 (en) * 2001-06-26 2009-10-13 The Regents Of The University Of California Compounds having activity as inhibitors of apoptosis
DE10150172A1 (de) * 2001-10-11 2003-04-30 Morphochem Ag Neue Verbindungen, die Protein Tyrosin Phosphatase 1B (PTP-1B) inhibieren
JP4991547B2 (ja) * 2004-09-28 2012-08-01 クアーク・ファーマスーティカルス、インコーポレイテッド 脱毛症、急性腎不全および他の疾患の治療のためのオリゴリボヌクレオチドおよびその使用の方法
US7825099B2 (en) * 2006-01-20 2010-11-02 Quark Pharmaceuticals, Inc. Treatment or prevention of oto-pathologies by inhibition of pro-apoptotic genes
US7910566B2 (en) * 2006-03-09 2011-03-22 Quark Pharmaceuticals Inc. Prevention and treatment of acute renal failure and other kidney diseases by inhibition of p53 by siRNA
KR101449057B1 (ko) 2006-03-17 2014-10-10 암비트 바이오사이언시즈 코포레이션 질환 치료용 이미다졸로티아졸 화합물
SI2170403T1 (sl) * 2007-06-27 2014-07-31 Quark Pharmaceuticals, Inc. Sestavki in postopki za inhibicijo ekspresije pro-apoptotskih genov
BRPI0816904B8 (pt) 2007-09-19 2021-12-07 Ambit Biosciences Corp Forma cristalna b da forma sólida do sal de bis-hcl, composição farmacêutica, e, uso de uma forma sólida
EP2218464A1 (de) * 2009-02-11 2010-08-18 Technische Universität München Verbindungen zur nichtinvasiven Messung von Aggregaten von Amyloidpeptiden
CN107417705B (zh) * 2017-07-24 2019-07-02 湘潭大学 咪唑并[2,1-b]苯并噻唑类化合物及其合成方法
IL279972A (en) * 2021-01-05 2022-08-01 Anima Biotech Inc Substances that function as modulators of cmyc-mrna translation and their uses in cancer treatment
JP2025523367A (ja) * 2022-07-03 2025-07-23 アニマ バイオテック インコーポレイテッド ｃ－ＭＹＣ ｍＲＮＡ翻訳調節因子及び癌治療におけるその使用
US12404283B2 (en) 2022-07-03 2025-09-02 Anima Biotech Inc. c-MYC mRNA translation modulators and uses thereof in the treatment of cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL129432C (de) * 1964-02-29
US4080339A (en) * 1973-09-20 1978-03-21 Pfizer Inc. Imidazo[2,1-b]thiazole and thiazolo[3,2-a]benzimidazole quaternary salts as hypoglycemic agents and growth promotants
GB1541321A (en) * 1976-03-10 1979-02-28 Metabio 2,3-dihydroimidazo(2,1-b)thiazole derivatives and process for their preparation
US4262004A (en) * 1979-06-21 1981-04-14 Janssen Pharmaceutica, N.V. 2,3-Dihydro-imidazo[2,1-b]benzothiazole compositions to treat depressions

Also Published As

Publication number Publication date
GB2056982A (en) 1981-03-25
ES494397A0 (es) 1981-08-01
ES8106535A1 (es) 1981-08-01
FR2463774A1 (fr) 1981-02-27
IT1166483B (it) 1987-05-06
IT8068303A0 (it) 1980-08-20
FR2463774B1 (de) 1983-10-21
DE3030982A1 (de) 1981-03-12
US4497817A (en) 1985-02-05
CA1158246A (en) 1983-12-06
GB2056982B (en) 1983-11-16

Similar Documents

Publication Publication Date Title
ATA10882A (de) Verfahren zur herstellung von neuen 6betahydroxyalkylpenicillansaeurederivaten
AT375078B (de) Verfahren zur herstellung von neuen indolizinderivaten
AT352716B (de) Verfahren zur herstellung von neuen derivaten des 2,3-dihydroimidazo (2,1-b)thiazols
AT369375B (de) Verfahren zur herstellung von neuen 3-vinylcephalosporin-derivaten
AT374200B (de) Verfahren zur herstellung von neuen halogenvincamonderivaten
AT373259B (de) Verfahren zur herstellung von neuen 1oxadethiacephalosporin-derivaten
AT380883B (de) Verfahren zur herstellung von neuen 1-oxo-1h -thiazolo(3,2-a)pyrimidin-2-carboxamiden
AT375941B (de) Verfahren zur herstellung von neuen 1-aminopyrazolo (1,5-c) chinazolinderivaten
AT380255B (de) Verfahren zur herstellung von neuen benzo-as-triazin-derivaten
AT372077B (de) Verfahren zur herstellung von neuen benzylidenderivaten
AT370725B (de) Verfahren zur herstellung von neuen 16-methoxy-16-methyl-prostaglandin-e1-derivaten
AT374798B (de) Verfahren zur herstellung von neuen aminoisochinolinderivaten
ATA21781A (de) Verfahren zur herstellung von neuen trans-6oxodecahydrochiniolinen
ATA64684A (de) Verfahren zur herstellung von neuen thiadiazolderivaten
AT369378B (de) Verfahren zur herstellung von neuen 3-thiovinyl-cephalosporinderivaten
AT375373B (de) Verfahren zur herstellung von neuen cephalosporin-derivaten
ATA639579A (de) Verfahren zur herstellung von neuen 7-(halogen- hydroxypropyl)-8-benzylaminotheophyllinen
AT375371B (de) Verfahren zur herstellung von neuen pyrido(3,2-e)-as-triazin-derivaten
ATA216083A (de) Verfahren zur herstellung von neuen 1-nitropyrazolo(1,5-c)chinazolinderivaten
ATA206582A (de) Verfahren zur herstellung von neuen 7-(2-
AT375648B (de) Verfahren zur herstellung von neuen carbostyrilderivaten
AT378534B (de) Verfahren zur herstellung von neuen ergopeptinderivaten
AT374480B (de) Verfahren zur herstellung von neuen 3-thiovinylcephalosporinderivaten
AT374167B (de) Verfahren zur herstellung von neuen naphthacenderivaten
AT374481B (de) Verfahren zur herstellung von neuen 3-thiovinylcephalosporinderivaten

Legal Events

Date Code Title Description
A1J Withdrawal paragraph 166 lit. 6